MARKER THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $6.2M | — |
| FY2017 | — | $3.7M | $5.1M |
| FY2018 | — | $59.3M | $61.7M |
| FY2019 | — | $44.1M | $43.9M |
| FY2020 | — | $27.3M | $21.4M |
| FY2021 | — | $44.0M | $42.4M |
| FY2022 | — | $19.6M | $11.8M |
| FY2023 | — | $14.1M | $15.1M |
| FY2024 | — | $18.6M | $19.2M |
| FY2025 | — | $16.8M | $16.1M |